{ }
Very Negative
Negative
Neutral
Positive
Very Positive
2025-04-072025-04-072025-04-082025-04-082025-04-092025-04-092025-04-102025-04-102025-04-112025-04-112025-04-132025-04-13213211124433221100
Download SVG
Download PNG
Download CSV
Somewhat Relevant
Moderately Relevant
Very Relevant
Highly Relevant
2025-04-072025-04-072025-04-082025-04-082025-04-092025-04-092025-04-102025-04-102025-04-112025-04-112025-04-132025-04-13111222314433221100
Download SVG
Download PNG
Download CSV

Nestlé's diverse product portfolio and global market presence detailed

Nestlé S.A., the world's leading food group, generates sales across various product families, including powdered and liquid beverages (26.7%), pet food (20.3%), and pharmaceutical, nutrition, and wellness products (16.4%). The company also offers prepared dishes and seasonings (12.5%), dairy products and ice creams (11.8%), chocolates and confectionery (8.7%), and packaged waters (3.6%). Geographically, sales are concentrated in the United States and Canada (35%), followed by Asia and Oceania (21.4%) and Latin America (13.7%).
15:59 17.10.2024

ubs rates nestle neutral with target price of 91 francs

UBS has rated Nestlé S.A. as 'Neutral' with a target price of 91 francs. As the largest food group globally, Nestlé's sales are diversified across various sectors, including beverages (26.7%), pet food (20.3%), and pharmaceuticals (16.4%), with significant market presence in the USA and Canada (35%).
15:59 17.10.2024

ECB cuts deposit rate as retail sales and job claims improve

The European Central Bank has lowered the deposit rate to 3.25% and the refinancing rate to 3.40%, marking the third consecutive cut amid slowing inflation. In the US, retail sales rose by 0.4%, surpassing expectations, while initial jobless claims fell to 241,000, offering a glimmer of hope for the economy. Investors are eyeing the 19,700-point level on the DAX, with the 19,500-point mark as a key support.
15:18 17.10.2024

startups transforming healthcare opportunities challenges and future innovations

In the inaugural episode of Checkpoint HealthTech, host Jan Thomas discusses the digital healthcare sector with investors Hendrik Steenfadt and Johannes Blaschke. They explore the slow pace of innovation in healthcare, the influence of major tech companies, and the challenges startups face, particularly in Europe where large exits remain rare. The conversation highlights the potential of technologies in prevention and telemedicine, emphasizing the sector's appeal to investors despite its hurdles.

urgent care telemedicine consultations market growth forecast and competitive landscape analysis

The Urgent Care Telemedicine Consultations Market is poised for significant growth from 2024 to 2031, driven by evolving consumer behaviors and technological advancements. Key players include Teladoc Health, Amwell, and MDLive, with a competitive landscape characterized by new product launches and strategic collaborations. The report provides in-depth analysis, including market segmentation, regional insights, and forecasts, equipping stakeholders with essential knowledge for navigating this dynamic industry.

global telemedicine market poised for significant growth and innovation by 2029

The global telemedicine market is projected to exceed USD 250 billion by 2029, growing at a CAGR of 17.22% from 2024 to 2029. Key drivers include increased adoption due to the pandemic, technological advancements, and the need for accessible healthcare, particularly in remote areas. However, challenges such as regulatory disparities and data privacy concerns persist across regions.

ubs maintains neutral rating for sartorius with target price of 264 euros

UBS AG maintains a "Neutral" rating for Sartorius vz shares with a target price of 264 euros, following third-quarter results that showed consolidated sales below expectations but an operating result in line with forecasts. The share price rose 13.9% to EUR 260.30, indicating potential for further growth, despite a 21.7% decline since the start of 2024. Sartorius is set to release its Q3 2024 results on October 17, 2024.
12:34 17.10.2024

UBS maintains buy rating for Merck with target price of 190 euros

UBS has maintained a "Buy" rating for Merck KGaA, setting a target price of 190 euros following the Group's Capital Markets Day. Analyst Matthew Weston noted that the new targets align with consensus estimates. Merck shares rose 5.7% to EUR 162.95, indicating a potential 16.6% upside. The Q3 2024 financial results are set to be released on November 14, 2024.
12:34 17.10.2024

ubs maintains buy rating for merck with target price of 190 euros

UBS AG has maintained a "Buy" rating for Merck KGaA, setting a target price of €190 following the Group's Capital Markets Day. The stock rose by 5.7% to €162.95, indicating a potential upside of 16.6%. Since the start of 2024, Merck's share price has increased by 14.7%, with Q3 2024 results expected on November 14.
12:34 17.10.2024

ubs maintains neutral rating on sartorius vz shares with target price of 264 euros

UBS AG has maintained a "Neutral" rating on Sartorius vz shares, setting a target price of 264 euros following the third-quarter results. While consolidated sales fell short of expectations, the operating result met forecasts, and a recovery in the BPS division may positively influence the market. Sartorius vz shares rose 13.9% in XETRA trading, though they have declined 21.7% since the start of 2024.
12:34 17.10.2024
Trending
Subcategory
Countries:
Companies:
Currencies:
People:

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Machinary - Dashboard

Client connection lost

Please check your connection. We try to reconnect...

Server connection lost

If our server is updating to a new version, please wait a moment before the service is available again.

Connection refused

All connection attempts have been rejected. This is most likely due to network problems or server problems.